[1] Grande I, Berk M, Birmaher B, et al. Bipolar disorder[J]. The Lancet, 2016, 387(10027): 1561-1572.
[2] Huang Y Q, Wang Y, Wang H, et al. Prevalence of mental disorders in China: A cross-sectional epidemiological study[J]. The Lancet Psychiatry, 2019, 6(3): 211-224.
[3] Judd L L, Akiskal H S, Schettler P J, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder[J]. Archives of General Psychiatry, 2003, 60(3): 261.
[4] Benedetti F. Rate of switch from bipolar depression into mania after morning light therapy: A historical review[J]. Psychiatry Research, 2018, 261: 351-356.
[5] Köhler S, Gaus S, Bschor T. The challenge of treatment in bipolar depression: Evidence from clinical guidelines, treatment recommendations and complex treatment situations[J]. Pharmacopsychiatry, 2014, 47(2): 53-59.
[6] Lam R W, Levitt A J, Levitan R D, et al. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder[J]. JAMA Psychiatry, 2016, 73(1): 56.
[7] Sit D, Wisner K L, Hanusa B H, et al. Light therapy for bipolar disorder: A case series in women[J]. Bipolar Disorders, 2007, 9(8): 918-927.
[8] Benedetti F, Colombo C. Sleep deprivation in mood disorders[J]. Neuropsychobiology, 2011, 64(3): 141-151.
[9] Leverich G S, Altshuler L L, Frye M A, et al. Risk of switch in mood polarity to hypomania or Mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers[J]. American Journal of Psychiatry, 2006, 163(2): 232-239.
[10] Etain B. Circadian abnormalities as markers of susceptibility in bipolar disorders[J]. Frontiers in Bioscience, 2014, S6(1): 120-137.
[11] Valenzuela F J, Vera J, Venegas C, et al. Evidences of polymorphism associated with circadian system and risk of pathologies: A review of the literature[J]. International Journal of Endocrinology, 2016, 2016: 2746909.
[12] Hasler G, Drevets W C, Gould T D, et al. Toward constructing an endophenotype strategy for bipolar disorders [J]. Biological Psychiatry, 2006, 60(2): 93-105.
[13] Martiny K, Volf C, Svendsen S D, et al. Psychiatry and circadian rhythms[J]. Ugeskrift for Laeger, 2018, 180(36): V04180278.
[14] Jermann F, Richard-Lepouriel H, Aubry J M. Lightdarkness and bipolar disorder[J]. Revue Medicale Suisse, 2020, 16(707): 1745-1747.
[15] Tseng P T, Chen Y W, Tu K Y, et al. Light therapy in the treatment of patients with bipolar depression: A meta-analytic study[J]. European Neuropsychopharmacology, 2016, 26(6): 1037-1047.
[16] Albrecht U. Circadian clocks and mood-related behaviors[J]. Handbook of Experimental Pharmacology, 2013(217): 227-239.
[17] Çalıyurt O. Role of chronobiology as a transdisciplinary field of research: Its applications in treating mood disorders[J]. Balkan Medical Journal, 2017, 34(6): 514-521.
[18] von Gall C. The effects of light and the circadian system on rhythmic brain function[J]. International Journal of Molecular Sciences, 2022, 23(5): 2778.
[19] Maynard M L, Zele A J, Kwan A S, et al. Intrinsically photosensitive retinal ganglion cell function, sleep efficiency and depression in advanced age-related macular degeneration[J]. Investigative Opthalmology & Visual Science, 2017, 58(2): 990.
[20] 方靓, 秦曦明, 朱道民. 双相情感障碍与生物节律相关生物机制研究进展[J]. 精神医学杂志, 2022, 35(1): 94-98.
[21] Bumb J M, Enning F, Mueller J K, et al. Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder[J]. Comprehensive Psychiatry, 2016, 68: 34-39.
[22] Bouwmans M E J, Bos E H, Booij S H, et al. Intra-and inter-individual variability of longitudinal daytime melatonin secretion patterns in depressed and non-depressed individuals[J]. Chronobiology International, 2015, 32(3): 441-446.
[23] Fang L, Yu Q M, Yin F F, et al. Combined cortisol and melatonin measurements with detailed parameter analysis can assess the circadian rhythms in bipolar disorder patients[J]. Brain and Behavior, 2021, 11(7): e2186.
[24] Valdés-Tovar M, Estrada-Reyes R, Solís-Chagoyán H, et al. Circadian modulation of neuroplasticity by melatonin: A target in the treatment of depression[J]. British Journal of Pharmacology, 2018, 175(16): 3200-3208.
[25] 杨丽, 任若佳, 王学义. 光照治疗抑郁症现状及其相关机制研究进展[J]. 中国神经精神疾病杂志, 2021, 47(11): 698-701.
[26] Barclay N L, Eley T C, Buysse D J, et al. Diurnal preference and sleep quality: Same genes? A study of young adult twins[J]. Chronobiology International, 2010, 27(2): 278-296.
[27] Huang M C, Chuang S C, Tseng M C M, et al. Cortisol awakening response in patients with bipolar disorder during acute episodes and partial remission: A pilot study[J]. Psychiatry Research, 2017, 258: 594-597.
[28] Minnetti M, Hasenmajer V, Pofi R, et al. Fixing the broken clock in adrenal disorders: Focus on glucocorticoids and chronotherapy[J]. Journal of Endocrinology, 2020, 246(2): R13-R31.
[29] Adamsson M, Laike T, Morita T. Annual variation in daily light exposure and circadian change of melatonin and cortisol concentrations at a northern latitude with large seasonal differences in photoperiod length[J]. Journal of Physiological Anthropology, 2016, 36(1): 6.
[30] Tyrer A E, Levitan R D, Houle S, et al. Serotonin transporter binding is reduced in seasonal affective disorder following light therapy[J]. Acta Psychiatrica Scandinavica, 2016, 134(5): 410-419.
[31] Sit D, Haigh S. Use of "lights" for bipolar depression[J]. Current Psychiatry Reports, 2019, 21(6): 45.
[32] 刘东歌, 肖晶晶, 刘宇昊, 等. 不同强度光照对双相抑郁患者疗效比较的随机对照研究[J]. 临床精神医学杂志, 2022, 32(5): 362-365.
[33] Clark C T, Wisner K L. Treatment of peripartum bipolar disorder[J]. Obstetrics and Gynecology Clinics of North America, 2018, 45(3): 403-417.
[34] Wirz-Justice A, Terman M. CME: Light therapy: Why, what, for whom, how, and when (and a postscript about darkness)[J]. Praxis, 2022, 111(2): 56-62.
[35] Wen J H, Sawmiller D, Wheeldon B, et al. A review for lithium: Pharmacokinetics, drug design, and toxicity[J]. CNS & Neurological Disorders-Drug Targets, 2020, 18(10): 769-778.
[36] DeVane C L. Pharmacokinetics, drug interactions, and tolerability of valproate[J]. Psychopharmacology Bulletin, 2003, 37(Suppl 2): 25-42.
[37] Geoffroy P A, Schroder C M, Bourgin P. Light treatment in depression: An Antique treatment with new insights [J]. Sleep Medicine Reviews, 2018, 40: 218-219.
[38] Takeshima M, Utsumi T, Aoki Y, et al. Efficacy and safety of bright light therapy for manic and depressive symptoms in patients with bipolar disorder: A systematic review and meta-analysis[J]. Psychiatry and Clinical Neurosciences, 2020, 74(4): 247-256.
[39] Hirakawa H, Terao T, Muronaga M, et al. Adjunctive bright light therapy for treating bipolar depression: A systematic review and meta-analysis of randomized controlled trials[J]. Brain and Behavior, 2020, 10(12): e1876.
[40] Yatham L N, Kennedy S H, Parikh S V, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder[J]. Bipolar Disorders, 2018, 20(2): 97-170.
[41] Dauphinais D R, Rosenthal J Z, Terman M, et al. Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression [J]. Psychiatry Research, 2012, 196(1): 57-61.
[42] Benedetti F, Riccaboni R, Locatelli C, et al. Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression[J]. The Journal of Clinical Psychiatry, 2014, 75(2): 133-140.
[43] Wang S J, Zhang Z G, Yao L, et al. Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis[J]. PLoS One, 2020, 15(5): e0232798.
[44] 任若佳, 卢文婷, 高媛媛, 等. 室内光照辅助治疗抑郁症的疗效与安全性研究[J]. 中国神经精神疾病杂志, 2023, 49(12): 720-726.
[45] Maruani J, Geoffroy P A. Bright light as a personalized precision treatment of mood disorders[J]. Frontiers in Psychiatry, 2019, 10: 85.
[46] Sit D K, McGowan J, Wiltrout C, et al. Adjunctive bright light therapy for bipolar depression: A randomized double-blind placebo-controlled trial[J]. American Journal of Psychiatry, 2018, 175(2): 131-139.
[47] Zhou T H, Dang W M, Ma Y T, et al. Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trial[J]. Journal of Affective Disorders, 2018, 227: 90-96.
[48] Do A, Li V W, Huang S, et al. Blue-light therapy for seasonal and non-seasonal depression: A systematic review and meta-analysis of randomized controlled trials [J]. The Canadian Journal of Psychiatry, 2022, 67(10): 745-754.
[49] 潘蓉, 廖继武, 潘集阳. 光照治疗抑郁发作的研究进展[J]. 临床精神医学杂志, 2022, 32(3): 249-252.
